KHALID USMAN; MUJEEB UR REHMAN; ARIF MUMTAZ; NASEEB URREHMAN; SALMAN KHAN. EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 28, n. 2, p. 418–422, 2021. DOI: 10.53555/jptcp.v28i2.6807. Disponível em: https://mail.jptcp.com/index.php/jptcp/article/view/6807. Acesso em: 18 nov. 2024.